Loading...
Loading...
In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on
LifePoint HospitalsLPNT.
In the report, Morgan Stanley noted, “Early benefits from reform exceeded expectations with a ~26% decline in self-pay admissions. LPNT now expects reform benefit to be at the high end of their guidance range of 4% to 5% of adj. EBITDA. However, underlying utilization trends remained an overhang on performance.”
LifePoint Hospitals closed on Friday at $56.87.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in